Upgrade to SI Premium - Free Trial

MannKind (MNKD) PT Raised to $6.50 at Oppenheimer

February 28, 2024 8:24 AM
Oppenheimer analyst Steven Lichtman raised the price target on MannKind (NASDAQ: MNKD) to $6.50 (from $5.50) while maintaining a Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles